We have the means to make a vaccine against pandemic flu. But quarrels over money, science and politics mean it could come too late, says Erika Check.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fedson, D. S. J. Pub. Health Pol. 26, 4–29 (2005).
Hehme, N., Engelmann, H., Kunzel, W., Neumeier, E. & Sanger, R. Med. Microbiol. Immunol. 191, 203–208 (2002).
Stephenson, I. et al. Lancet 362, 1959–1966 (2003).
Wood, J. M. & Robertson, J. S. Nature Rev. Microbiol. 2, 842–847 (2004).
Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G. & Webster, R. G. Proc. Natl Acad. Sci. USA 97, 6108–6113 (2000).
Subbarao, K. et al. Virology 305, 192–200 (2003).
Lipatov, A. S., Webby, R. J., Govorkova, E. A., Krauss, S. & Webster, R. G. J. Infect. Dis. 191, 1216–1220 (2005).
Webby, R. J. et al. Lancet 363, 1099–1103 (2004).
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
Race for pandemic flu vaccine rife with hurdles
WHO calls for vaccine boost to prepare for flu pandemic
'Reverse genetics' could offer forward-thinking flu vaccine
Avian flu raises vaccine questions
Related external links
Rights and permissions
About this article
Cite this article
Check, E. Is this our best shot?. Nature 435, 404–406 (2005). https://doi.org/10.1038/435404a
Published:
Issue Date:
DOI: https://doi.org/10.1038/435404a
This article is cited by
-
Mechanism of NKT cell activation by intranasal coadministration of α-galactosylceramide, which can induce cross-protection against influenza viruses
Mucosal Immunology (2008)
-
Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses
Virology Journal (2006)
-
Flu-vaccine makers toil to boost supply
Nature (2006)
-
Inactivation of influenza A virus by gentian violet (GV) and GV-dyed cotton cloth, and bactericidal activities of these agents
Journal of Infection and Chemotherapy (2006)
-
Rapid-response vaccines—does DNA offer a solution?
Nature Biotechnology (2005)
